Rial, N. S., Zell, J. A., Cohen, A. M., & Gerner, E. W. (2012). Clinical endpoints for developing pharmaceuticals to manage patients with sporadic or genetic risk of colorectal cancer.
Citação norma ChicagoRial, Nathaniel S., Jason A. Zell, Alfred M. Cohen, and Eugene W. Gerner. Clinical Endpoints for Developing Pharmaceuticals to Manage Patients With Sporadic or Genetic Risk of Colorectal Cancer. 2012.
MLA CitationRial, Nathaniel S., Jason A. Zell, Alfred M. Cohen, and Eugene W. Gerner. Clinical Endpoints for Developing Pharmaceuticals to Manage Patients With Sporadic or Genetic Risk of Colorectal Cancer. 2012.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.